Atenolol Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition
Atenolol Price Trend, Index and Forecast
Track the latest insights on atenolol price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.
Atenolol Prices Outlook Q3 2025
- Germany: USD 334/KG
- Brazil: USD 405/KG
- USA: USD 358/KG
- Thailand: USD 559/KG
- India: USD 364/KG
Atenolol Price Chart
Get real-time access to monthly/quaterly/yearly prices, Request Sample
During the third quarter of 2025, the atenolol prices in Germany reached 334 USD/KG in September. Prices were influenced by steady pharmaceutical demand and elevated production costs. Supply constraints from key active pharmaceutical ingredient (API) manufacturers led to higher procurement costs. Transportation and logistics expenses within Europe increased slightly, affecting final pricing.
During the third quarter of 2025, the atenolol prices in Brazil reached 405 USD/KG in September. Prices were impacted by a higher domestic manufacturing costs and moderate fluctuations in imported API prices. Increased energy and logistics expenses affected local pharmaceutical companies, while fluctuating currency exchange rates slightly raised import bills. Expanding demand from public healthcare programs also supported price fluctuations.
During the third quarter of 2025, the atenolol prices in the USA reached 358 USD/KG in September. Prices were driven by a sustained demand from the cardiovascular drug segment and higher costs for imported APIs. Domestic production margins were affected by increased compliance and testing costs under FDA supervision. Shipping and warehousing expenses remained high throughout the quarter, adding to total operational costs.
During the third quarter of 2025, the atenolol prices in Thailand reached 559 USD/KG in September. The price change was primarily driven by heightened demand from regional pharmaceutical formulators and increased input costs. Import dependency for atenolol APIs amplified cost sensitivity to exchange rate fluctuations. Rising freight charges and elevated customs clearance fees further influenced final market prices. Domestic formulation manufacturers faced challenges due to higher energy and labor expenses.
During the third quarter of 2025, the atenolol prices in India reached 364 USD/KG in September. Prices were supported by robust domestic demand and a marginal rise in raw material and solvent costs. Export volumes to major Western markets expanded, reducing domestic inventory levels. Freight and logistics rates increased slightly due to fuel adjustments, while compliance and testing costs under revised pharmaceutical norms exerted additional price pressure.
Atenolol Prices Outlook Q2 2025
- Germany: USD 331/KG
- Brazil: USD 400/KG
- USA: USD 350/KG
- Thailand: USD 551/KG
- India: USD 359/KG
During the second quarter of 2025, the atenolol prices in Germany reached 331 USD/KG in June. Prices were supported by consistent demand from the generic pharmaceutical sector. Minor disruptions in API supply from Asian exporters led to small price adjustments. Logistic expenses were moderate, while strong currency performance helped control import costs. Regulatory inspection cycles created minor production slowdowns.
During the second quarter of 2025, the atenolol prices in Brazil reached 400 USD/KG in June. Prices were influenced by moderate demand recovery in domestic formulations. Import costs remained under control, although periodic shipping delays affected local inventories. Fluctuations in the Brazilian Real slightly influenced API procurement costs. Stable energy prices and controlled logistics spending prevented sharper increases, resulting in a steady but firm market tone during the quarter.
During the second quarter of 2025, the atenolol prices in the USA reached 350 USD/KG in June. Prices were driven by a higher procurement activity from formulation manufacturers. While domestic production was stable, moderate increases in transportation and packaging costs influenced price movements. Regulatory scrutiny and batch-testing costs under quality assurance programs slightly raised operating expenses.
During the second quarter of 2025, the atenolol prices in Thailand reached 551 USD/KG in June. The movement was supported by firm regional demand and the tight supply of imported atenolol. Shipping delays, coupled with increased customs clearance costs, added to price pressure. Local pharmaceutical manufacturers experienced moderate increases in solvent and chemical reagent prices. Nevertheless, balanced production activity across the region kept prices within a range through the quarter.
During the second quarter of 2025, the atenolol prices in India reached 359 USD/KG in June. Prices reflected rising input costs for intermediates and utilities. Consistent export orders to global pharmaceutical markets supported steady offtake. Domestic manufacturing costs increased marginally owing to higher fuel and packaging rates. Despite stable availability, mild inflationary trends in logistics maintained atenolol pricing across Indian markets during Q2 2025.
Regional Coverage
The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing atenolol prices.
Asia Pacific Atenolol Price Trend
Q3 2025:
In Q3 2025, atenolol prices in Asia Pacific were supported by high consumption in India, Thailand, and Southeast Asian countries. Strong export activity toward Western pharmaceutical firms limited regional inventories. Higher raw material and solvent costs, coupled with increased port congestion and freight rates, affected pricing dynamics. Government policies promoting local API manufacturing moderately offset import dependency, but did not fully mitigate price escalation across the region.
Q2 2025:
During Q2 2025, atenolol prices in the Asia Pacific region witnessed fluctuations, supported by balanced supply-demand conditions across major producing nations such as India, Thailand, and China. Strong manufacturing output and favorable export activity sustained market stability despite mild cost inflation. Rising labor expenses and higher utility tariffs marginally increased production costs for regional formulators, but efficient logistics networks and domestic API availability offset these impacts.
This atenolol price analysis can be expanded to include a comprehensive list of countries within the region.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Atenolol Price Trend
Q3 2025:
During Q3 2025, atenolol prices in Latin America rose moderately due to sustained demand from domestic drug formulators and higher import costs. Supply interruptions from major exporting nations temporarily constrained availability. Currency fluctuations and increased port logistics expenses further contributed to pricing firmness. Expanding healthcare coverage across the region also encouraged consistent consumption, sustaining moderate market trends.
Q2 2025:
In Q2 2025, atenolol prices in Latin America remained firm amid stable market fundamentals and consistent pharmaceutical consumption. Brazil, the region’s dominant producer and consumer, reported steady manufacturing activity supported by favorable API imports. Demand from public health initiatives and private-sector procurement continued to drive formulation requirements. Although freight charges and customs clearance fees increased marginally, efficient supply chain management and improved port operations reduced transit delays.
This comprehensive review can be extended to include specific countries within the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Europe Atenolol Price Trend
Q3 2025:
During Q3 2025, the atenolol price index in Europe showed moderate appreciation across key markets, including Germany and France. Demand from cardiovascular therapeutic drug producers increased steadily, while API supply constraints from Asian exporters exerted upward pressure on costs. Rising energy tariffs, stricter environmental compliance, and labor costs further elevated European manufacturing expenses. Freight surcharges and port-handling costs also contributed to higher transaction values across the region. Overall, sustained demand and rising operational costs supported a firm European market sentiment.
Q2 2025:
During Q2 2025, the atenolol price index in Europe were influenced by steady API inflows and balanced demand across key pharmaceutical markets such as Germany, France, and Italy. The availability of imported raw materials from Asian suppliers ensured smooth production schedules for European formulators. Controlled energy pricing and moderate logistics costs helped sustain cost efficiency, offsetting minor inflationary pressures from packaging and regulatory compliance. Demand from cardiovascular drug manufacturers remained steady, driven by stable prescription volumes in hospital and retail segments.
This analysis can be extended to include detailed atenolol price information for a comprehensive list of countries.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Atenolol Price Trend
Q3 2025:
During Q3 2025, the atenolol price index in North America increased moderately due to firm pharmaceutical demand and consistent import dependency. Manufacturing costs in the United States and Canada were influenced by higher compliance requirements and testing expenses. Freight rate adjustments and packaging material costs added incremental pricing pressure. Despite stable API inflows, slightly longer shipping times from Asia constrained inventory flow. Consequently, atenolol prices exhibited stable movement across North American markets.
Q2 2025:
During Q2 2025, the atenolol price index in North America displayed limited fluctuations, with prices holding steady amid adequate API availability and consistent pharmaceutical consumption. Supply continuity from Asian exporters ensured that US and Canadian formulators maintained healthy production levels throughout the quarter. Manufacturing costs increased slightly due to rising expenses for utilities, quality control, and packaging materials, yet these were balanced by stable freight rates and efficient domestic logistics. Regulatory compliance and inspection cycles under FDA and Health Canada oversight contributed modestly to production costs but did not disrupt supply chains significantly.
Specific atenolol historical data within the United States and Canada can also be provided.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Middle East and Africa Atenolol Price Trend
Q3 2025:
The report explores the atenolol trends and atenolol price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
Q2 2025:
As per the atenolol price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences.
In addition to region-wise data, information on atenolol prices for countries can also be provided.
| Region | Countries Covered |
|---|---|
| Middle East & Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Atenolol Pricing Report, Market Analysis, and News
IMARC's latest publication, “Atenolol Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition,” presents a detailed examination of the atenolol market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of atenolol at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed atenolol prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting atenolol pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.
Atenolol Market Analysis
The global atenolol market size reached USD 12.76 Billion in 2025. By 2034, IMARC Group expects the market to reach USD 18.98 Billion, at a projected CAGR of 4.51% during 2026-2034. The market is primarily driven by the rising demand for cardiovascular medications, expansion in generic pharmaceutical manufacturing, and increasing healthcare expenditure in emerging economies.
Latest News and Developments:
- June 2025: A recent pharmacokinetic review highlighted atenolol’s sensitivity to fruit juice interactions. Studies showed that co-administration of atenolol with orange juice significantly reduced its absorption, with marked decreases in systemic exposure and peak plasma concentration. Similar results were reported when atenolol was consumed with varying volumes of apple juice, indicating substantial impairment in drug bioavailability.
Product Description
Atenolol belongs to the group of drugs known as beta-blockers and is used to control cardiovascular disorders such as hypertension, angina, and arrhythmia. It is cardio selective as it selectively inhibits β1 receptor unlike β-2 receptors that exist in the lungs and are important in the exercise of bronchodilation in asthmatic patients.
Atenolol is also well suited for use as a prophylactic treatment for migraine and is available in an oral tablet and injectable dosages to offer further options in treatment. The additional benefit of once-daily dosing is that it helps with the patients’ treatment compliance to the medication. Atenolol is also in form of generic drugs, and this makes it readily accessible and affordable, a factor that fuels its application in clinical settings.
Report Coverage
| Key Attributes | Details |
|---|---|
| Product Name | Atenolol |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Atenolol Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand* Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru* Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco* *The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of atenolol pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting atenolol price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The atenolol price charts ensure our clients remain at the forefront of the industry.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Request Customization
Inquire Before Buying
Speak to an Analyst
Request Brochure
Benefits of Customization
- Personalize this research
- Triangulate with your data
- Get data as per your format and definition
- Gain a deeper dive into a specific application, geography, customer, or competitor
- Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-201-971-6302
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
Client Testimonials
.webp)
.webp){kind=logo}
Why Choose Us
IMARC offers trustworthy, data-centric insights into commodity pricing and evolving market trends, enabling businesses to make well-informed decisions in areas such as procurement, strategic planning, and investments. With in-depth knowledge spanning more than 1000 commodities and a vast global presence in over 150 countries, we provide tailored, actionable intelligence designed to meet the specific needs of diverse industries and markets.
1000
+Commodities
150
+Countries Covered
3000
+Clients
20
+Industry
Robust Methodologies & Extensive Resources
IMARC delivers precise commodity pricing insights using proven methodologies and a wealth of data to support strategic decision-making.
Subscription-Based Databases
Our extensive databases provide detailed commodity pricing, import-export trade statistics, and shipment-level tracking for comprehensive market analysis.
Primary Research-Driven Insights
Through direct supplier surveys and expert interviews, we gather real-time market data to enhance pricing accuracy and trend forecasting.
Extensive Secondary Research
We analyze industry reports, trade publications, and market studies to offer tailored intelligence and actionable commodity market insights.
Trusted by 3000+ industry leaders worldwide to drive data-backed decisions. From global manufacturers to government agencies, our clients rely on us for accurate pricing, deep market intelligence, and forward-looking insights.